HUMACYTE INC (HUMA): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy HUMACYTE INC (HUMA) following the 2026 Q1 hedge fund 13F filings?

As of today, HUMA has moved -1.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +1.4% for the XLV sector ETF — an outperformance of -2.8%. Since the quarter end (March 31, 2026), HUMA gained +51.7% vs +0.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

HUMACYTE INC (HUMA)

158 + Investors. Track Smart Money conviction in HUMA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — HUMA

Based on 158 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added HUMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

📊

High ownership — 93% of 3.0Y peak

93% of all-time peak

158 funds currently hold this stock — 93% of the 3.0-year high of 169 funds (reached 2025 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

📉

Outflows — 7% fewer funds vs a year ago

fund count last 6Q

11 fewer hedge funds hold HUMA compared to a year ago (-7% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.

🟢

More buyers than sellers — 62% buying

88 buying53 selling

Last quarter: 88 funds were net buyers (33 opened a brand new position + 55 added to an existing one). Only 53 were sellers (34 trimmed + 19 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+10 vs last Q)

new funds entering per quarter

Funds opening a new HUMA position: 32 → 17 → 23 → 33. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

📌

Mixed — 34% long-term, 25% new

■ 34% conviction (2yr+) ■ 41% medium ■ 25% new

Of the 158 current holders: 54 (34%) held >2 years, 64 held 1–2 years, and 40 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💎

Buying through price weakness — shares +8%, value -32%

Value

-31%

+7%

Last quarter: funds added +8% more shares while total portfolio value only changed -32%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📈

Growing discovery — still being found

38 → 32 → 17 → 23 → 33 new funds/Q

New funds entering each quarter: 32 → 17 → 23 → 33. A growing number of institutions are discovering HUMA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Deep conviction — 40% of holders stayed 2+ years

■ 40% veterans ■ 27% 1-2yr ■ 33% new

Of 162 current holders: 64 (40%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

✅

Strong quality — 34% AUM from major funds

34% from top-100 AUM funds

34 of 158 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

3.3

out of 10

Low Exit Risk

Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	158	144	9.72%
13F Shares	61M	56M	7.88%
Total Value	$37M	$54M	-31.95%
New Positions	33	23	+10
Increased Positions	53	55	-2
Closed Positions	19	20	-1
Reduced Positions	33	35	-2
Total Calls	4	4	-
Total Puts	3	3	-
PUT/CALL Ratio	0.75	0.75	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

158

144

9.72%

13F Shares

61M

56M

7.88%

Total Value

$37M

$54M

-31.95%

New Positions

+10

Increased Positions

-2

Closed Positions

-1

Reduced Positions

-2

Total Calls

Total Puts

PUT/CALL Ratio

0.75

Neutral

Institutional Holders (2026 Q1)

158 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in HUMA. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 institutional holders of HUMA — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Lion Point Capital, LP	2.36%	650,000	$394K
2	GREAT POINT PARTNERS LLC	0.52%	3,750,000	$2.3M
3	ANTIPODES PARTNERS Ltd	0.07%	5,723,750	$3.5M
4	Imprint Wealth LLC	0.05%	16,363	$10K
5	WEALTH EFFECTS LLC	0.04%	204,500	$124K
6	Endowment Wealth Management, Inc.	0.03%	105,418	$64K
7	LJI Wealth Management, LLC	0.03%	277,500	$168K
8	R Squared Ltd	0.02%	62,911	$38K
9	Clarus Wealth Advisors	0.01%	39,971	$24K
10	United Asset Strategies, Inc.	0.01%	209,608	$127K
11	HAMILTON LANE ADVISORS LLC	0.01%	21,893	$13K
12	GSA CAPITAL PARTNERS LLP	0.01%	249,856	—
13	Shay Capital LLC	0.01%	173,020	$105K
14	Trust Co of Kansas	0.01%	24,000	—
15	COLUMBIA ADVISORY PARTNERS LLC	0.01%	19,958	$12K
16	LaSalle St. Investment Advisors, LLC	0.01%	69,644	$42K
17	Clearview Wealth Management LLC	0.01%	13,000	$8K
18	NINE MASTS CAPITAL Ltd	0.00%	54,535	$33K
19	Woodline Partners LP	0.00%	2,002,582	$1.2M
20	XTX Topco Ltd	0.00%	412,090	$250K
21	LAZARI CAPITAL MANAGEMENT, INC.	0.00%	13,144	$8K
22	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.00%	210,000	$127K
23	Private Advisor Group, LLC	0.00%	832,799	$505K
24	Kovack Advisors, Inc.	0.00%	72,600	$44K
25	ACT WEALTH MANAGEMENT, LLC	0.00%	11,379	$7K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — HUMACYTE INC (HUMA)

What does the Smart Money Trend signal show for HUMA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added HUMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for HUMA?

More buyers than sellers — 62% buying: Last quarter: 88 funds were net buyers (33 opened a brand new position + 55 added to an existing one). Only 53 were sellers (34 trimmed + 19 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for HUMA holders?

Strong quality — 34% AUM from major funds: 34 of 158 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held HUMA?

Mixed — 34% long-term, 25% new: Of the 158 current holders: 54 (34%) held >2 years, 64 held 1–2 years, and 40 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy HUMACYTE INC (HUMA) following the 2026 Q1 hedge fund 13F filings?

As of today, HUMA has moved -1.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +1.4% for the XLV sector ETF — an outperformance of -2.8%. Since the quarter end (March 31, 2026), HUMA has gained +51.7% vs +0.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

HUMACYTE INC (HUMA)

Smart Money Signals — HUMA

Buying streak — 2 quarters in a row

High ownership — 93% of 3.0Y peak

Outflows — 7% fewer funds vs a year ago

More buyers than sellers — 62% buying

More new buyers each quarter (+10 vs last Q)

Mixed — 34% long-term, 25% new

Buying through price weakness — shares +8%, value -32%

Growing discovery — still being found

Deep conviction — 40% of holders stayed 2+ years

Strong quality — 34% AUM from major funds

Institutional Sentiment Summary — HUMA

Hedge Fund Ownership: HUMA

Market Analysis: HUMA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: HUMA

Is It Too Late to Buy HUMACYTE INC (HUMA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: HUMA

Statistics: HUMA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — HUMACYTE INC (HUMA)

Welcome to 13Foresight!